Twelve metabolites of a synthetic cannabinoid, EAM-2201, were being tentatively determined in human hepatocytes in vitro, and in human liver and urine specimens in vivo for the first time. In vitro effects point out that AM-2201 ought to be examined for probable pharmacokinetic drug interactions in vivo on account of https://hemalchem.com/product-category/am-series/